Literature DB >> 27075761

Hydroxocobalamin-attributed risk of oxalate nephropathy: evidence is not sufficient to change the recommended management of cyanide toxicity by fire smoke inhalation.

Bruno Mégarbane1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27075761     DOI： 10.1007/s00134-016-4354-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients.

Authors:  Matthieu Legrand; Thibault Michel; Michel Daudon; Mourad Benyamina; Axelle Ferry; Sabri Soussi; Véronique Maurel; Maïte Chaussard; Marc Chaouat; Maurice Mimoun; Jérôme Verine; Vincent Mallet; Alexandre Mebazaa
Journal:  Intensive Care Med       Date:  2016-02-18       Impact factor: 17.440

2.  Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs.

Authors:  Stephen W Borron; Michael Stonerook; Frances Reid
Journal:  Clin Toxicol (Phila)       Date:  2006       Impact factor: 4.467

Review 3.  Hydroxocobalamin in cyanide poisoning.

Authors:  John P Thompson; Timothy C Marrs
Journal:  Clin Toxicol (Phila)       Date:  2012-11-19       Impact factor: 4.467

4.  Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation.

Authors:  Stephen W Borron; Frédéric J Baud; Patrick Barriot; Michel Imbert; Chantal Bismuth
Journal:  Ann Emerg Med       Date:  2007-05-04       Impact factor: 5.721
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.